Outlook With the rapid advancement of the economy and society, coupled with continuous improvements in living standards, the prevalence of metabolic disorders like obesity, diabetes, hypertension, hyperlipidemia and hyperuricemia, is on the rise
3-methylcrotonyl-CoA carboxylase, 3-Methylcrotonyl-CoA carboxylase (3MCC), like PCC, is also a heterododecameric enzyme (subunit composition: 6 6 )
Clinical trials show an average of 1517% body weight reduction over 68 weeks
Given the heterogeneity of HF, metabolic interventions may be particularly effective in patients with defined phenotypes
Evidence for an Oxyntomodulin Action
this is the case for, e.g., Lactobacillus acidophilus , Lactobacillus plantarum , and Lactobacillus reuteri